Target intelligence / Profile preview

Polyvalent cations in the gastrointestinal tract

Molecular classification
Inorganic ion, Metal ion, Other
01

Overview

Polyvalent cations in the gastrointestinal tract refer to a group of multivalent metal ions, such as calcium (Ca2+), magnesium (Mg2+), aluminum (Al3+), and iron (Fe2+/Fe3+), that play a pivotal role in the pharmacokinetics of numerous oral medications [1, 2]. These ions are prevalent in the gut due to dietary intake (e.g., dairy products), mineral supplements, and common over-the-counter products like antacids and laxatives [11, 18]. From a pharmacological perspective, they act as targets for chelation, where they form stable, insoluble complexes with drugs including fluoroquinolone and tetracycline antibiotics, bisphosphonates, and HIV integrase inhibitors [3, 4, 14]. This complexation prevents the drug from being absorbed across the intestinal epithelium, leading to significantly reduced systemic exposure and potential therapeutic failure [5, 6]. Beyond their role in drug interactions, polyvalent cations like lanthanum and calcium are therapeutically employed as phosphate binders to treat hyperphosphatemia in chronic kidney disease by sequestering dietary phosphate in the gut [7, 10]. Understanding the behavior of these cations is essential for optimizing drug delivery and avoiding clinically significant drug-nutrient or drug-drug interactions [1, 11].

Other names
Multivalent cationsDivalent and trivalent cationsChelating cationsDietary mineralsMetal ions
02

Mechanism of action

Chelation and formation of insoluble, non-absorbable complexes in the gastrointestinal lumen, which significantly reduces the bioavailability of co-administered medications.

03

Biological functions

Electrolyte homeostasisEnzymatic cofactorBone mineralizationSignal transduction
04

Disease associations

HyperphosphatemiaMineral deficiencyDrug-drug interactionsMalabsorption
05

Safety considerations

Reduced therapeutic efficacy of co-administered drugsTreatment failure (e.g., antibiotic resistance, loss of viral suppression)ConstipationElectrolyte imbalanceGastrointestinal distress
06

Interacting drugs

Dolutegravir

11 more in the full profile.

07

Biomarkers

Serum drug concentration (Cmax/AUC)Serum phosphate levelsSerum calcium levelsSerum magnesium levelsSerum iron levels

Beyond the preview

Go deeper on Polyvalent cations in the gastrointestinal tract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Polyvalent cations in the gastrointestinal tract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call